Cochrane2024IaEN
Cochrane Review: Ultrasound and blind endometrial sampling for detection of endometrial cancer in women with postmenopausal bleeding
Zusammenfassung
# Ultrasound and blind endometrial sampling for detection of endometrial cancer in women with postmenopausal bleeding.
This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows: To assess the diagnostic accuracy of endometrial sampling with histology in the diagnosis of endometrial cancer in women with postmenopausal bleeding and thickened endometrium on ultrasound. Diagnosis will be verified by the reference standards, hysteroscopy with histology, obtained by targete
Kerninformationen
ancer To assess the diagnostic accuracy of endometrial sampling devices and methods to detect endometrial hyperplasia To determine accuracy in diagnosing endometrial cancer and endometrial hyperplasia at different endometrial thicknesses of 3 mm, 4 mm and 5 mm To investigate sources of heterogeneity...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cancer Council Australia2026
Clinical Practice Guidelines for the Treatment and Management of Endometrial Cancer
Cochrane2022
Cochrane Review: Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women
Cochrane2021
Cochrane Review: Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer
Cochrane2020
Cochrane Review: Health education interventions to promote early presentation and referral for women with symptoms of endometrial cancer
Cochrane2025
Cochrane Review: Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
Cochrane2020
Cochrane Review: Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
Cochrane2019
Cochrane Review: Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer
Cochrane2025